Description

Adhesive bandages are designed to protect the wound from further injury, infection, and dirt. They create a barrier that prevents bacteria and other harmful substances from entering the wound and causing further damage. They also help to keep the wound moist, which can promote faster healing. There are many different types of adhesive bandages available, including those made from plastic, fabric, or silicone. They come in various shapes and sizes, from small circular bandages to larger rectangular ones. Some adhesive bandages are also infused with medications, such as antiseptics or pain relievers, to provide additional protection and comfort. The adhesive bandages market in Asia Pacific is likely to register a CAGR of over 4.2% with an incremental growth of USD 175.6 million during the forecast period 2023-2028.

The report provides up-to-date market size data for period 2019-2022 and forecast to 2028 covering key market aspects like sales value and volume for adhesive bandages. The Asia Pacific adhesive bandages market is segmented on the basis of distribution channel, and country. Por canal de distribuição, the adhesive bandages market in Asia Pacific has been segmented into grocery stores and supermarkets, drug stores and pharmacies, e-commerce, and others. In terms of geography, the adhesive bandages market in Asia Pacific has been segmented into Australia, China, Índia, Indonésia, Japão, Filipinas, South Korea, Tailândia, Vietnã, and others.

The Asia Pacific adhesive bandages market is highly competitive. Top players covered in Asia Pacific Adhesive Bandages Market Study are 3M Company, Band Doctor Co. Ltd., Beiersdorf AG, CG Bio Inc., Convatec Group plc, Forest Holdings Inc., Fujimoto Holdings Co. Ltd., Glory Ray Holdings Limited, Hakujuji Co. Ltd., Ildong Pharmaceutical Co. Ltd., Jack Chia Industries (Tailândia) Public Company Limited, Johnson & Johnson (J&J), JW Shinyak Corporation, Kobayashi Pharmaceutical Co. Ltd., Mundipharma International Limited, NICHIBAN Co. Ltd., Paul Hartmann AG, Sato Pharmaceutical Co. Ltd., SinSin Pharmaceutical Co. Ltd., Smith & Nephew plc, Yunnan Baiyao Group Co. Ltd., Yutoku Pharmaceutical Ind Co. Ltda.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the adhesive bandages market to help drive informed decision making for industry executives, decisores políticos, academic, and analysts.

Escopo do relatório

Canal de distribuição: grocery stores and supermarkets, drug stores and pharmacies, e-commerce, and others
País: Austrália, China, Índia, Indonésia, Japão, Filipinas, South Korea, Tailândia, Vietnã, and others
Years considered: this report covers the period 2019 to 2028

Key Benefits for Stakeholders

Get a comprehensive picture of the Asia Pacific adhesive bandages market
Identify regional strategies and strategic priorities on the basis of local data
Pinpoint growth sectors and trends for investment

Índice

1. Market definition
2. Research methodology
3. Market overview
4. Adhesive bandages market by distribution channel
4.1 Grocery stores and supermarkets
4.2 Drug stores and pharmacies
4.3 E-commerce
4.4 Others
5. Adhesive bandages market by country
5.1 Austrália
5.2 China
5.3 Índia
5.4 Indonésia
5.5 Japão
5.6 Filipinas
5.7 South Korea
5.8 Tailândia
5.9 Vietnã
5.10 Others
6. Company profiles
6.1 3M Company
6.2 Band Doctor Co. Ltda.
6.3 Beiersdorf AG
6.4 CG Bio Inc.
6.5 Convatec Group plc
6.6 Forest Holdings Inc.
6.7 Fujimoto Holdings Co., Ltda.
6.8 Glory Ray Holdings Limited
6.9 Hakujuji Co., Ltda.
6.10 Ildong Pharmaceutical Co., Ltda.
6.11 Jack Chia Industries (Tailândia) Public Company Limited
6.12 Johnson & Johnson (J&J)
6.13 JW Shinyak Corporation
6.14 Kobayashi Pharmaceutical Co., Ltda.
6.15 Mundipharma International Limited
6.16 NICHIBAN Co., Ltda.
6.17 Paul Hartmann AG
6.18 Sato Pharmaceutical Co., Ltda.
6.19 SinSin Pharmaceutical Co., Ltda.
6.20 Smith & Nephew plc
6.21 Yunnan Baiyao Group Co., Ltda.
6.22 Yutoku Pharmaceutical Ind Co., Ltda.
7. Appendix
7.1 About StrategyHelix
7.2 Disclaimer